Zhejiang Conba Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 27.21% vs -7.38% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 294.07% vs -144.59% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,905.50",
          "val2": "1,497.90",
          "chgp": "27.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "242.70",
          "val2": "59.80",
          "chgp": "305.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "1.80",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.80",
          "val2": "-50.80",
          "chgp": "61.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "203.00",
          "val2": "-104.60",
          "chgp": "294.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "127.40%",
          "val2": "-19.40%",
          "chgp": "14.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -0.21% vs -3.19% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -25.33% vs -2.42% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,422.10",
          "val2": "6,435.60",
          "chgp": "-0.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "857.90",
          "val2": "907.20",
          "chgp": "-5.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.40",
          "val2": "21.80",
          "chgp": "-56.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "29.70",
          "chgp": "-101.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "491.60",
          "val2": "658.40",
          "chgp": "-25.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "78.80%",
          "val2": "86.00%",
          "chgp": "-0.72%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,905.50

1,497.90

27.21%

Operating Profit (PBDIT) excl Other Income

242.70

59.80

305.85%

Interest

1.50

1.80

-16.67%

Exceptional Items

-19.80

-50.80

61.02%

Consolidate Net Profit

203.00

-104.60

294.07%

Operating Profit Margin (Excl OI)

127.40%

-19.40%

14.68%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 27.21% vs -7.38% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 294.07% vs -144.59% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

6,422.10

6,435.60

-0.21%

Operating Profit (PBDIT) excl Other Income

857.90

907.20

-5.43%

Interest

9.40

21.80

-56.88%

Exceptional Items

-0.50

29.70

-101.68%

Consolidate Net Profit

491.60

658.40

-25.33%

Operating Profit Margin (Excl OI)

78.80%

86.00%

-0.72%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -0.21% vs -3.19% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -25.33% vs -2.42% in Dec 2024

All Annual Results